By CERBIOS-PHARMA SA
Cerbios-Pharma presents PROVEO Integrated Solutions for ADC Manufacturing at World ADC San Diego
Lugano, Switzerland: – CDMO specialist Cerbios-Pharma SA (Cerbios) will be a high profile presence at the 13th Annual World ADC conference in San Diego, presenting case studies regarding PROVEO solution for ADC development and manufacturing. The conference will take place from the 6th – 9th September at the Sheraton San Diego Hotel and Marina.
CMC Stream Presentation
Dr. Vítor Sousa, CDMO Business Development Manager, will be presenting on day 1 of the conference a talk on ‘PROVEO: Integrated Solutions for ADC Manufacturing’. The main topics of discussion will be:
- Showcasing a tailored service platform with a clear and flexible contractual framework
- Discussing a simplified supply chain
- Starting materials to DS and DP
- Complete integrated Project Management system
- The importance of a coordinated Quality System
- Supporting Manufacturing network
PROVEO, a division of Cerbios-Pharma SA, offers a fully integrated end-to-end service for the development and manufacturing of ADCs, from early development stages to clinical trials and commercial supply. Along with its partners AGC Biologic and Oncotec Pharma Produktion GmbH, PROVEO covers the whole supply chain of ADCs, from cell line development and mAbs to payload, conjugation and aseptic filling.
PROVEO offers tremendous advantages to its customers, summarized in simplified documentation and single contractual partner, full integration and complete supply chain. PROVEO is one of the most active CDMO in this field: in the last years, PROVEO has worked with the main players in the ADC field worldwide.
Alongside Dr. Sousa, the Cerbios and Proveo team at ADC World San Diego will include Cerbios-Pharma Chief Commercial Officer (CCO) Denis Angioletti, Business Developer Filippo Caragnano and Biological R&D Manager Valentina Gualato, along with Matthias Beck, Manager of New Business Development, for Oncotec Pharma Produktion GmbH, representing Proveo partners.
Together, they will be participating in the range of networking activities coordinated by Hanson Wade.
Cerbios is a privately held company located in Lugano, Switzerland, specialized in manufacturing Pharma Products and in offering CDMO services.
Cerbios is the ideal CDMO partner from clinical to commercial supply of API, HPAPIs, Payloads, ADCs, Proteins and Antibodies. Services offered include Process & Analytical Development, Scale-up and Clinical Supply, Industrial Validation, Commercial Supply, Full CMC Regulatory Support. Proveo (TM) is a Cerbios division recently created to provide end-to-end development and manufacturing services for ADCs.
Cerbios is also a global leading supplier of a portfolio of Generic APIs primarily used in Oncology and for the treatment of Respiratory and Dermatological disorders. Cerbios has additionally a 40 years’ experience in the probiotics field: the portfolio includes a FDF based on proprietary strain SF68® for treatment of diarrhea and dysbiosis by antibiotics and two new Food Supplements for the management of ACNE & Seborrheic dermatitis and to boost immune response.
Learn more at: https://cerbios.swiss
About World ADC San Diego
The World ADC Conference is the industry’s longest standing and most comprehensive event devoted to Antibody Drug Conjugate technology and solutions.
The event aims to generate new insights and connections to promote development of more clinically impactful ADCs.
The 13th conference, World ADC San Diego 2022, will be a four-day event opening September 6th at the Sheraton San Diego Hotel and Marina.
The long awaited event will be running for the first time in-person since 2019 for its ADC enthusiasts. This year’s meeting looks deeper into the resurgence of ADCs being used as combination therapies, next generation payloads, and how to evolve your manufacturing processes in this fast-paced and ever-evolving field.
The event is organized by Hanson Wade with more information at: https://worldadc-usa.com/